Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002035782-24-000002
Filing Date
2024-08-29
Accepted
2024-08-29 17:57:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4681
  Complete submission text file 0002035782-24-000002.txt   6321
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Subject) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93186 | Film No.: 241265144
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5513 W 11000 N PMB 548 HIGHLAND UT 84003
Business Address 5513 W 11000 N PMB 548 HIGHLAND UT 84003 8013621122
Olmsted Investments LLC (Filed by) CIK: 0002035782 (see all company filings)

EIN.: 862700117 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SCHEDULE 13G